Disgren (triflusal) capsules 300 mg. №30

$59.00

Manufacturer: Germany

Purpose: Inhibits platelet aggregation to prevent blood clots in cardiovascular diseases.

SKU: MED57902 Category:

Description

Disgren (triflusal) Capsules 300 mg. №30

Composition:

Each capsule contains 300 mg of triflusal as the active ingredient.

Mechanism of Action:

Triflusal, a platelet aggregation inhibitor, works by preventing the formation of blood clots.

Pharmacological Properties:

Triflusal exerts its antiplatelet effects by inhibiting thromboxane A2 synthesis, thereby reducing platelet aggregation.

Indications for Use:

Disgren capsules are indicated for the prevention of thrombotic events in patients with a history of myocardial infarction or unstable angina.

Contraindications:

Avoid using Disgren capsules if you have a known hypersensitivity to triflusal or any other component of the product.

Side Effects:

Common side effects may include gastrointestinal disturbances, such as dyspepsia and gastritis. In rare cases, allergic reactions like rash or angioedema may occur.

Usage Instructions:

The recommended dosage is one 300 mg capsule daily, to be taken orally with food. Swallow the capsule whole with a full glass of water. Do not crush or chew the capsule.

Benefits Compared to Analogues:

Triflusal has shown similar efficacy to aspirin in preventing thrombotic events but with a lower incidence of gastrointestinal side effects, making it a favorable option for patients at risk.

Suitable Patient Groups:

Disgren capsules are suitable for adult patients, including the elderly population, with a history of myocardial infarction or unstable angina.

Storage and Shelf Life:

Store Disgren capsules in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use the product beyond that date.

Packaging Description:

Disgren capsules are available in a pack of 30 capsules, each containing 300 mg of triflusal.

Clinical Evidence and Proven Effectiveness:

Triflusal has been studied extensively for its efficacy in preventing thrombotic events. Clinical trials have demonstrated its effectiveness in reducing the risk of recurrent cardiovascular events in high-risk patients. In comparative studies with aspirin, triflusal showed similar efficacy with a more favorable gastrointestinal side effect profile.